Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker
Cancer is a disease with abnormally proliferating cells and therefore proliferation rate is an important index for assessing tumour growth. Ki-67 is a commonly used proliferation marker considered to be an unfavourable prognostic marker in some tumors, while Thymidine kinase 1 (TK1) is an interestin...
Saved in:
Main Authors: | Jianjun Wang, Qi Liu, Xiaodie Zhou, Yan He, Qing Guo, Qunli Shi, Staffan Eriksson, Ji Zhou, Ellen He, Sven Skog |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-06-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317706479 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative immunohistochemical study of ki-67, p53, caspase-3 in distal colonic polyps and colorectal adenocarcinoma.
by: M. A. Shyskin
Published: (2019-09-01) -
Characterization and analysis of Ki-67-immunoreactivity in brain astrocytoma
by: Shpon‘ka I.S., et al.
Published: (2016-03-01) -
Characterization and analysis of Ki-67-immunoreactivity in brain astrocytoma.
by: I. S. Shpon‘ka, et al.
Published: (2016-04-01) -
Thymidine Kinase 1 Expression Correlates with Tumor Aggressiveness and Metastatic Potential in OSCC
by: Chia-Jung Lee, et al.
Published: (2025-06-01) -
Blood biomarkers and Ki-67 proliferation marker in breast cancer
by: A. A. Studenikina, et al.
Published: (2023-04-01)